Giovanni Del Fabro

6PUBLICATIONS
17CO-AUTHORS
Major global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Medical virologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Baseline Predictors of Adverse Outcome and Survival in Adults Hospitalized with Invasive Pneumococcal Disease.

|Jun 16, 2026
Eravacycline in sepsis complicated by Clostridioides difficile infection: a brief case series.

|Jan 17, 2025
Can nCD64 and mCD169 biomarkers improve the diagnosis of viral and bacterial respiratory syndromes in the emergency department? A prospective cohort pilot study.

Sergio Venturini, Massimo Crapis, Agnese Zanus-Fortes

|Dec 18, 2024
Role of MR-proADM and Monocyte CD169 in Predicting In-Hospital and 60-Day Mortality in COVID-19 Patients.

Sergio Venturini, Daniele Orso, Francesco Cugini

|May 16, 2024
Time is running out. No excuses to delay implementation of antimicrobial stewardship programmes: impact, sustainability, resilience and efficiency through an interrupted time series analysis (2017-2022).

Giovanni Del Fabro, Sergio Venturini, Manuela Avolio

|Dec 23, 2023
Actinomyces spp. Prosthetic Vascular Graft Infection (PVGI): A Multicenter Case-Series and Narrative Review of the Literature.

Giovanni Del Fabro, Sara Volpi, Benedetta Fumarola

Pageof 1

Frequent Collaborators

4 joint publications

Ingrid Reffo

3 joint publications

Sergio Venturini

2 joint publications

Daniele Orso

2 joint publications

Chiara Pratesi